Skip to main content

J Lim

First name:
J
Last name:
Lim
Nam, S. ., Chen, X. ., Lim, J. ., Kim, S. ., Kim, S. ., Cho, Y. ., … Park, S. . (2011). In vivo fluorescence imaging of bacteriogenic cyanide in the lungs of live mice infected with cystic fibrosis pathogens. PloS One, 6(7), e21387. https://doi.org/10.1371/journal.pone.0021387 (Original work published 2011)
Lim, J. ., Lee, K. ., Kim, S. ., Kim, Y. ., Kim, S. ., Park, W. ., & Park, S. . (1969). YkgM and ZinT proteins are required for maintaining intracellular zinc concentration and producing curli in enterohemorrhagic Escherichia coli (EHEC) O157:H7 under zinc deficient conditions. International Journal of Food Microbiology. https://doi.org/10.1016/j.ijfoodmicro.2011.06.017 (Original work published)
Jo, Y. ., Kim, S. ., Koh, K. ., Park, J. ., Shim, Y. ., Lim, J. ., … Han, K. . (2011). Reliable, accurate determination of the leukocyte differential of leukopenic samples by using hematoflow method. The Korean Journal of Laboratory Medicine, 31(3), 131-7. https://doi.org/10.3343/kjlm.2011.31.3.131 (Original work published 2011)
Lee, J. ., Lim, J. ., Chung, Y. ., Chung, S. ., Park, I. ., Kim, C. ., & You, J. . (2018). Targeted Temperature Management at 33°C or 36°C Produces Equivalent Neuroprotective Effects in the Middle Cerebral Artery Occlusion Rat Model of Ischemic Stroke. Shock (Augusta, Ga.). https://doi.org/10.1097/SHK.0000000000001106 (Original work published 2018)
Sakimoto, K. ., Kornienko, N. ., Cestellos-Blanco, S. ., Lim, J. ., Liu, C. ., & Yang, P. . (2018). Physical Biology of the Materials-Microorganism Interface. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.7b11135 (Original work published 2018)
Pivot, X. ., Bondarenko, I. ., Nowecki, Z. ., Dvorkin, M. ., Trishkina, E. ., Ahn, J. ., … Lim, J. . (2018). Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive.. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017740126. https://doi.org/10.1200/JCO.2017.74.0126 (Original work published 2018)
Reilley, M. ., Bailey, A. ., , Janku, F. ., Naing, A. ., Falchook, G. ., … Hong, D. . Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. Journal for Immunotherapy of Cancer, 5, 35. https://doi.org/10.1186/s40425-017-0238-1 (Original work published 2017)